Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Matthew Friedman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- John W. Childs - $20.71M in MANE purchases and sales in the last 12 months
- Longitude Capital Partners V, LLC - $18.27M in MANE purchases and sales in the last 12 months
- Patrick G. Enright - $18.27M in MANE purchases and sales in the last 12 months
- Reid Alexander Waldman - $7.28M in MANE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Matthew Friedman?
David Matthew Friedman is a corporate insider of Benitec Biopharma Inc. (BNTC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David Matthew Friedman last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 2 filings going back to 2026.
